Evidence map›Paper›PMID 41023314›Full record

ArticleMolecular neurobiology2025

Correction: Evaluating the Predictive Value of Oxylipins for Cognitive Measures and White Matter Hyperintensities in Alzheimer's Disease Continuum Compared to Conventional Beta‑amyloid and Tau Protein Biomarkers.

Alireza Shaabanpoor Haghighi, Mahsa Mayeli, Elham Ramezannezhad, Negin Pouroushaninia, Rezvan Barzegar Parizi, Mahtab Nourollahi-Foumeshi, Nasim Idelkhani, Zahra Dadjou, Niloofar Saeedipour, Negar Safaee and 5 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Alireza Shaabanpoor HaghighiSchool of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Mahsa MayeliDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
Elham RamezannezhadSchool of Medicine, Isfahan University of Medical Science, Isfahan, Iran.
Negin PouroushaniniaSchool of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
Rezvan Barzegar PariziDepartment of Clinical Psychology, Islamic Azad University, Sirjan, Iran.
Mahtab Nourollahi-FoumeshiDepartment of Biology, Faculty of Basic Sciences and Engineering, Gonbad Kavous University, Gonbad-E Kavus, Iran.
Nasim IdelkhaniStudent's Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Zahra DadjouTabriz University, Tabriz, Iran.
Niloofar SaeedipourDepartment of Psychology, Central Tehran Branch Azad University, Tehran, Iran.
Negar SafaeeSchool of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
Homa PartoandazSchool of Medicine, Iran University of Medical Science, Tehran, Iran.
Mahan ShafieSchool of Medicine, Tehran University of Medical Science, Tehran, Iran.
Mohammad SadeghiSchool of Medicine, Tehran University of Medical Science, Tehran, Iran.
Marjan FalahatiDepartment of Pharmaceutical Science, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran. marjanfar96@gmail.com.
Alzheimer’s Disease Neuroimaging Initiative

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41023314

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.